-
Listen in to a talk with Travis Tyler Fluck, an educator, end-of-life doula, and psychedelic activist. With 29 years of experience working with psilocybin mushrooms and a lifetime explore liminal spaces, Travis brings profound insights and healing potential. From leading the Denver Psilocybin Initiative to co-founding the Denver Mushroom Cooperative, his impact reaches far and wide.
-
Iboga is a transformative West African Master Teacher Plant best known for its unmatched results for treating alcoholism and opioid addiction. Learn more about the incredible healing potential of this remarkable medicine along with the medical precautions, and safest practices… and hear stories from those whose lives have been transformed by this powerful medicine.
-
Psilocybin mushrooms contain compounds that are capable of promoting rapid and sustained neuroplasticity. Listen in to hear expert Travis Fluck, from Denver Mushroom Cooperative, on the best ways to work with this medicine.
-
Is Ketamine a psychedelic? How is ketamine used medicinally? What are the differences between lozenges, IM, IV? Should you choose at home ketamine or clinical use? How to spot misuse and overuse in the community and the dangers of ketamine addiction.
-
Listen in to hear facilitators, Daan Keiman and Lindsay Branham who have been offering above board, legal psilocybin services for years in the Netherlands. They discussed what to expect in a ceremony, how to determine if psychedelics are right for you, and how to choose a facilitator.
-
The symposium ended with a keynote address titled "Speculations on the Antiquity of Human Consciousness" by Dennis Mckenna, who has conducted research in ethnopharmacology for over 40 years. He is a founding board member of the Heffter Research Institute and was a key investigator on the Hoasca Project, the first biomedical investigation of ayahuasca.
-
In the fourth panel of the day, “Where do we go from here?” panelists discussed the many questions around what access might look like in the years ahead, why harm reduction efforts are an important next step, and how the conversation should continue.
-
In the third panel of the day, “The Neuroscience of Psychedelics,” speakers discussed how researchers have been exploring the neurobiological mechanisms of psychedelic drugs, the resulting changes in brain activity, and what treating chronic pain with psychedelics looks like.
-
The second panel of the day, “Mental Health Breakthroughs,” was directed at those struggling to heal from depression, anxiety or substance use disorder, where psilocybin –and other psychedelic-assisted therapies– can offer hope.
-
In this first panel of the day, “What is Healing, What is Ceremony?” panelists explored the history and contemporary practice of healing through plant-based medicines, exploring cultural and ceremonial use, the nature of healing, human experience and transformation with an overview of psychedelics today.